AECOM (ACM)
NYSE: ACM · Real-Time Price · USD
111.04
-1.70 (-1.51%)
Aug 1, 2025, 2:51 PM - Market open
Marinus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 9 analysts that cover Marinus Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $122.56, which forecasts a 10.37% increase in the stock price over the next year. The lowest target is $109 and the highest is $137.
Price Target: $122.56 (+10.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Marinus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 4 | 4 | 4 | 5 | 5 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $122 → $137 | Strong Buy | Maintains | $122 → $137 | +23.38% | Jul 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $120 → $129 | Buy | Maintains | $120 → $129 | +16.17% | Jul 16, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $123 → $126 | Buy | Maintains | $123 → $126 | +13.47% | May 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $116 → $122 | Strong Buy | Maintains | $116 → $122 | +9.87% | May 7, 2025 |
| Baird | Baird | Buy Maintains $108 → $118 | Buy | Maintains | $108 → $118 | +6.27% | May 6, 2025 |
Financial Forecast
Revenue This Year
16.64B
from 16.11B
Increased by 3.29%
Revenue Next Year
17.63B
from 16.64B
Increased by 5.98%
EPS This Year
5.20
from 2.95
Increased by 76.22%
EPS Next Year
5.72
from 5.20
Increased by 10.01%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17.4B | 18.6B | 18.9B |
| Avg | 16.6B | 17.6B | 18.2B |
| Low | 15.9B | 17.0B | 17.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 8.1% | 12.0% | 7.1% |
| Avg | 3.3% | 6.0% | 3.0% |
| Low | -1.4% | 2.0% | -0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.46 | 6.09 | 6.70 | ||
| Avg | 5.20 | 5.72 | 6.28 | ||
| Low | 5.00 | 5.34 | 5.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 85.1% | 17.1% | 17.1% | ||
| Avg | 76.2% | 10.0% | 9.8% | ||
| Low | 69.3% | 2.7% | 3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.